Subtype
Ovarian Sex Cord-Stromal Tumor
CI-CAN-00003551Explore in graph →
Non-malignant4 active trials11 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003551Explore in graph →
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05348356 | Nirogacestat in Ovarian Granulosa Cell Tumors | completed | Phase 2 | 53 | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY | 3 | Aug 25, 2026 | clinicaltrials |
| NCT06328491 | Erdafitinib in Metastatic Steroid-cell Ovarian Cancer | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06254781 | Luspatercept in Metastatic AGCT of the Ovary | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT00565903 | Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome |
Data updated 23 days agoSource updated Aug 25, 2026source: clinicaltrials
| completed |
| — |
| 1,247 |
| Ashley HillOTHER |
| 1 |
| Mar 1, 2023 |
| clinicaltrials |
| NCT01770301 | Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)(ALIENOR) | completed | Phase 2 | 60 | ARCAGY/ GINECO GROUPOTHER | 1 | Jul 2, 2021 | clinicaltrials |
| NCT00006227 | Paclitaxel in Treating Patients With Ovarian Stromal Cancer | completed | Phase 2 | 31 | Gynecologic Oncology GroupNETWORK | 2 | Mar 5, 2020 | clinicaltrials |
| NCT00748657 | Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |